MARCHI, ENRICA
MARCHI, ENRICA
The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma
2015 Marchi, Enrica; Zullo, Kelly M; Amengual, Jennifer E; Kalac, Matko; Bongero, Danielle; Mcintosh, Christine M; Fogli, Laura K; Rossi, Maura; Zinzani, Pier L; Pileri, Stefano A; Piccaluga, Pier P; Fuligni, Fabio; Scotto, Luigi; O'Connor, Owen A
Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies.
2010 Marchi E; Paoluzzi L; Scotto L; Seshan VE; Zain JM; Zinzani PL; O'Connor OA.
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma.
2007 Zinzani PL; Tani M; Trisolini R; Fanti S; Stefoni V; Alifano M; Castellucci P; Musuraca G; Dalpiaz G; Alinari L; Marchi E; Fina M; Pellegrini C; Farsad M; Cancellieri A; Busca A; Canini R; Pileri S; Baccarani M; Boaron M.
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.
2006 Zinzani PL.; Tani M.; Fanti S.; Alinari L.; Musuraca G.; Marchi E.; Stefoni V.; Castellucci P.; Fina M.; Farshad M.; Pileri S.; Baccarani M.
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.
2005 ZINZANI P.; DIRNHOFER S; SABATTINI E; ALINARI L; PICCALUGA PP; STEFONI V; TANI M; MUSURACA G; MARCHI E; FALINI B; BACCARANI M; PILERI SA.
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
2004 ZINZANI P.; STEFONI V; MUSURACA G; TANI M; ALINARI L; GABRIELE A; MARCHI E; PILERI S; BACCARANI M.
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience
2004 ZINZANI P.L.; TANI M.; GABRIELE A.; GHERLINZONI F.; DE VIVO A.; RICCI P.; BANDINI G.; LEMOLI R.M.; MOTTA M.R.; RIZZI S.; GUIDICE V.; ZOMPATORI M.; STEFONI V.; ALINARI L.; MUSURACA G.; MARCHI E.; BASSI S.; CONTE R.; PILERI S.; TURA S.; BACCARANI M.
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine
2004 ZINZANI PL; TANI M; MARCHI E; STEFONI V; ALINARI L; MUSURACA G; GABRIELE A; PILERI S; BACCARANI M.
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.
2004 Zinzani, PIER LUIGI; Fanti, Stefano; Battista, Giuseppe; Tani, Monica; Castellucci, Paolo; Stefoni, Vittorio; Alinari, Lapo; Farsad, M; Musuraca, G; Gabriele, A; Marchi, Enrica; Nanni, C; Canini, Romeo; Monetti, Nino; Baccarani, Michele
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma | Marchi, Enrica; Zullo, Kelly M; Amengual, Jennifer E; Kalac, Matko; Bongero, Danielle; Mcintosh, ...Christine M; Fogli, Laura K; Rossi, Maura; Zinzani, Pier L; Pileri, Stefano A; Piccaluga, Pier P; Fuligni, Fabio; Scotto, Luigi; O'Connor, Owen A | 2015-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies. | Marchi E; Paoluzzi L; Scotto L; Seshan VE; Zain JM; Zinzani PL; O'Connor OA. | 2010-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma. | Zinzani PL; Tani M; Trisolini R; Fanti S; Stefoni V; Alifano M; Castellucci P; Musuraca G; Dalpia...z G; Alinari L; Marchi E; Fina M; Pellegrini C; Farsad M; Cancellieri A; Busca A; Canini R; Pileri S; Baccarani M; Boaron M. | 2007-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients. | Zinzani PL.; Tani M.; Fanti S.; Alinari L.; Musuraca G.; Marchi E.; Stefoni V.; Castellucci P.; F...ina M.; Farshad M.; Pileri S.; Baccarani M. | 2006-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. | ZINZANI P.; DIRNHOFER S; SABATTINI E; ALINARI L; PICCALUGA PP; STEFONI V; TANI M; MUSURACA G; MAR...CHI E; FALINI B; BACCARANI M; PILERI SA. | 2005-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. | ZINZANI P.; STEFONI V; MUSURACA G; TANI M; ALINARI L; GABRIELE A; MARCHI E; PILERI S; BACCARANI M. | 2004-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience | ZINZANI P.L.; TANI M.; GABRIELE A.; GHERLINZONI F.; DE VIVO A.; RICCI P.; BANDINI G.; LEMOLI R.M....; MOTTA M.R.; RIZZI S.; GUIDICE V.; ZOMPATORI M.; STEFONI V.; ALINARI L.; MUSURACA G.; MARCHI E.; BASSI S.; CONTE R.; PILERI S.; TURA S.; BACCARANI M. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine | ZINZANI PL; TANI M; MARCHI E; STEFONI V; ALINARI L; MUSURACA G; GABRIELE A; PILERI S; BACCARANI M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. | Zinzani, PIER LUIGI; Fanti, Stefano; Battista, Giuseppe; Tani, Monica; Castellucci, Paolo; Stefon...i, Vittorio; Alinari, Lapo; Farsad, M; Musuraca, G; Gabriele, A; Marchi, Enrica; Nanni, C; Canini, Romeo; Monetti, Nino; Baccarani, Michele | 2004-01-01 | BRITISH JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |